BCVA can remain deceptively stable until late RP and becomes insensitive at profound vision loss, motivating ...

We enrolled 130 cataract patients whose best-corrected visual acuity (BCVA) was 20/40 or better preoperatively. Objective visual functions were evaluated with a KR-1W analyzer before and at 1 month ...

Please provide your email address to receive an email when new articles are posted on . The functional visual acuity system and contrast visual acuity facilitate the evaluation of visual disturbances ...

Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

An investigational gene therapy has shown promise for improving functional vision and restoring light detection in long-dormant rods and cones in the retina in adults and children with a rare form of ...